Product NDC: | 66993-164 |
Proprietary Name: | glimepiride |
Non Proprietary Name: | glimepiride |
Active Ingredient(s): | 4 mg/1 & nbsp; glimepiride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66993-164 |
Labeler Name: | PRASCO LABORATORIES |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020496 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20090618 |
Package NDC: | 66993-164-02 |
Package Description: | 100 TABLET in 1 BOTTLE (66993-164-02) |
NDC Code | 66993-164-02 |
Proprietary Name | glimepiride |
Package Description | 100 TABLET in 1 BOTTLE (66993-164-02) |
Product NDC | 66993-164 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | glimepiride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090618 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | PRASCO LABORATORIES |
Substance Name | GLIMEPIRIDE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |